1.2380
+0.0380
+(3.17%)
At close: 4:00:00 PM EDT
1.2400
+0.00
+(0.16%)
After hours: 4:05:05 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | -- | -- | 6.1M | 5.5M |
| Low Estimate | -- | -- | 6.1M | 5.5M |
| High Estimate | -- | -- | 6.1M | 5.5M |
| Year Ago Sales | -- | -- | 3.5M | 6.1M |
| Sales Growth (year/est) | -- | -- | 74.52% | -9.84% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -- | -0.06 | -0.07 | -0.04 |
| EPS Actual | -0.07 | -0.07 | -0.01 | -0.05 |
| Difference | -- | -0.01 | 0.06 | -0.01 |
| Surprise % | -- | -7.69% | 85.71% | -25.00% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| DYAI | -- | -- | -- | -- |
| S&P 500 | 6.40% | 6.07% | 9.36% | 14.28% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/14/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 7/8/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/13/2023 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/24/2023 |
| Reiterates | HC Wainwright & Co.: Buy | 2/3/2023 |
| Downgrade | Dawson James: Buy to Neutral | 7/18/2022 |
Related Tickers
PYPB.F IXICO plc
0.0855
+1.18%
CHM.AX Chimeric Therapeutics Limited
0.0050
0.00%
ALA.AX Arovella Therapeutics Limited
0.0820
+1.23%
CYTOF Altamira Therapeutics Ltd.
0.0601
0.00%
QBIO Q BioMed Inc.
0.0001
0.00%
RADX Radiopharm Theranostics Limited
4.4650
+1.71%
EXOZ eXoZymes, Inc.
10.90
-7.39%
KTTAW Pasithea Therapeutics Corp.
0.0199
-33.44%
MTVA MetaVia Inc.
1.4500
+5.07%
LVTX LAVA Therapeutics N.V.
1.0900
+0.93%